FSBEI HE I.P.Pavlov SPbSMU MOH Russia

Saint Petersburg 197022

0 studies enrolling now · 3 studies all time

What they study most

Complete Response, Dermatitis, Dermatitis, Atopic, Eczema, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Genetic Diseases, Inborn, Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, Newly Diagnosed

Studies at this site

• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects — Completed